Magnevist (SH L 451A) Intra-individual Dose Comparison Study in Patients With Brain Metastasis

Clinical trial NCT00681551 · COMPLETED

Trial details

NCT number: NCT00681551
Sponsor: Bayer
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Brain Neoplasms

Start date: 2003-02-01
Enrollment: 45

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.